Hepatitis C drug can cure, if patients can get it
BALTIMORE — A wonder drug came on the market two years ago that cures hepatitis C, a potentially deadly liver disease afflicting millions of Americans, killing 15,000 a year. The problem is, many patients could not afford it. A standard course of ...
Hanford Sentinel - Mon, 03 Aug 2015 15:41

Utah woman says clinical trial cured her hepatitis C
SALT LAKE CITY — Researchers at Intermountain Medical Center said they found a cure for hepatitis C, a common virus. The hospital led the worldwide 12 to 24 week clinical trial, testing 660 patients, half of them from the U.S.. Utah resident Gina ...
KSL.com - Sat, 01 Aug 2015 10:58

Utah -- clinical trial cures woman of hepatitis C
TheHealthSite - Sun, 02 Aug 2015 05:33

Docs stress on public education on hepatitis C
Times of India - Fri, 31 Jul 2015 07:48

Tennessee Dept. of Health issues public health advisory on hepatitis C
Fx Report Daily - Thu, 30 Jul 2015 21:52

Hepatitis C: People need to Deal With It
Yorkton News Review - Thu, 30 Jul 2015 12:59

New hepatitis C combination treatment effective in HIV coinfected patients
Worldwide, hepatitis C virus (HCV) infection affects up to a quarter of people with HIV type 1 (HIV-1), accelerating the onset of liver disease. Now, results of an open-label study suggest that treatment with the NS5A inhibitor daclatasvir, together ...
The Pharmaceutical Journal - Mon, 03 Aug 2015 08:33

For hepatitis C patients, costlier pill worth it
WASHINGTON – The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors in the U.S.. The new leading pill for hepatitis C is more expensive, and the number of patients seeking a ...
Baxter Bulletin - Mon, 03 Aug 2015 14:33

'Amazing' drug to cost NM Medicaid $140M
Albuquerque Journal - Sun, 02 Aug 2015 23:00

New Mexico Medicaid program spending millions on drug
KRQE News 13 - Mon, 03 Aug 2015 11:45

Costly to Treat, Hepatitis C Gains Quietly in US
Zach Wayman says he first contracted hepatitis C several years ago by sharing needles with other heroin addicts. He went into rehab and was successfully treated for the virus. But he relapsed into addiction and reinfected himself, testing positive for ...
New York Times - Thu, 23 Jul 2015 12:44

Tennessee Dept. of Health issues public health advisory on hepatitis C epidemic
The rate of acute Hepatitis C cases in Tennessee has more than tripled in the last seven years, and the steadily increasing number of cases may only represent “the tip of the iceberg” of the state's Hepatitis-C epidemic, according to TDH Commissioner ...
WATE 6 On Your Side - Mon, 27 Jul 2015 10:10

Hepatitis C triples in Tennessee; public health advisory issued
Chattanooga Times Free Press - Mon, 27 Jul 2015 10:26

Over 100K Tennesseans unaware they have hepatitis C
The Tennessean - Mon, 27 Jul 2015 18:42

Warning about hepatitis C issued by TN health officials
WSMV Nashville - Tue, 28 Jul 2015 10:04

World Hepatitis Day: We have a cure for Hepatitis C, but it's not offered to ...
The Independent - Tue, 28 Jul 2015 02:39

TDH issues public health advisory on hepatitis C epidemic
Local 8 Now - Mon, 27 Jul 2015 14:11

State Health Department warns about Hepatitis C virus
WBIR-TV - Mon, 27 Jul 2015 15:52

Gilead's Hepatitis C Dominance Unchecked By AbbVie
Worries that Gilead Sciences (NASDAQ:GILD) market dominance in treating hepatitis C would falter following the launch of AbbVie's (NYSE:ABBV) Viekira Pak this year have been mostly curbed after Gilead Sciences' stellar second quarter. Despite Viekira ...
Motley Fool - Thu, 30 Jul 2015 05:00

Gilead Won't Run Out of Hep C Patients, or Dollars, Anytime Soon
Bloomberg - Thu, 30 Jul 2015 06:52

Gilead hepatitis C drugs build road to Japan
San Francisco Business Times (blog) - Wed, 29 Jul 2015 16:46

Eyeing big returns, drugmakers ready new hepatitis-C drug launches
Medical Marketing and Media - Wed, 29 Jul 2015 13:31

Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge
Gilead Sciences Inc., maker of the hepatitis C drugs Sovaldi and Harvoni, posted second-quarter profit that topped analysts' estimates as revenue surged. Gilead raised its sales forecast for the year. Earnings excluding one-time items rose to $3.15 a ...
Bloomberg - Tue, 28 Jul 2015 13:19

Hepatitis C drugs account for 60% of the drug company's second quarter revenue
ModernHealthcare.com - Wed, 29 Jul 2015 07:54

Pricey hepatitis C drugs help Gilead eclipse big sales threshold
San Francisco Business Times (blog) - Tue, 28 Jul 2015 13:56

Gilead Sales Soar on Hepatitis Drugs
Wall Street Journal - Tue, 28 Jul 2015 13:15

UPDATE 2-Gilead hepatitis C sales beat Wall Street, sales outlook raised
Reuters - Tue, 28 Jul 2015 13:53

The Path to a Cure for Hepatitis C in People with HIV
AIDS.gov blog (blog) - Mon, 27 Jul 2015 15:52

As Cases of Hepatitis C Surge, Many Cannot Afford the Best Treatment
Youth Health Magzine - Mon, 27 Jul 2015 15:20

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014